A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer

NCT03100955 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Progression Free Survival

Interventions

DRUG: cisplatin, etoposide
DRUG: cisplatin, etoposide, apatinib

Sponsor

Qingdao University